Introduction 600-800 ng/ml (polyclonal antibody measured by radioimmunoassay (Abbot)) for the initial 6 months and a level of 400-600 ng/ml thereafter. Prednisolone Post-transplant diabetes mellitus (PTDM ) is a wellwas administered at 60 mg/day for 2 days, then reduced recognized clinical problem following renal transto 30 mg/day and gradually tapered over 6 months to plantation, and occurs with incidence rates that range a maintenance dose of 10 mg/day. An initial pulse of between 2.5 and 20% [1] [2] [3] [4] . Despite this high incidence, 500 mg methylprednisolone was also given as part of there are very few reported cases of diabetic nephroour protocol. pathy of the diffuse type [5, 6 ] and only a single report Eight months later the patient developed PTDM of the nodular sclerosis form [7] .
manifested by persistent hyperglycaemia of more than We report (i) patient who developed PTDM 8 11 mmol/l. Glibenclamide was prescribed. Good glycamonths after renal transplantation, with progression emic control was achieved until 1992 when she required to the nephrotic syndrome and end-stage renal failmetformin. Her renal function remained stable with a ure due to typical diabetic nodular sclerosis of creatinine of 120 mmol/l. She had no proteinuria. Kimmelstiel-Wilson, and (ii) patients who developed
In 1994 rejection was diagnosed clinically and the PTDM 6 months and 2 years after renal transplantapatient responded to three pulses of methylprednisotion respectively, who progressed to the nephrotic lone 500 mg. Her glycaemic control deteriorated for a syndrome with impaired renal function due to diffuse short period, but was re-established by adjusting the diabetic glomerulosclerosis.
oral hypoglycaemic medications. The patient was lost to follow-up for 11 months before she presented in December 1995 with proCases teinuria of 3.46 g/day, serum albumin of 32 g/l, and markedly impaired renal function, i.e. serum creatinine Case 1 of 340 mmol/l. There was no retinopathy on fundal A 48-year-old woman who was neither diabetic nor examination. A graft biopsy showed advanced diabetic hypertensive presented with chronic renal failure. glomerulosclerosis with extensive interstitial fibrosis She had no family history of diabetes mellitus and and hyaline arteriosclerosis. The glomeruli showed her kidney ultrasound demonstrated bilateral small both diffuse and nodular sclerosis with characteristic kidneys.
Kimmelstiel-Wilson lesions ( Figure 2 ) and capsular She was maintained on haemodialysis for 30 months drops. There was no evidence of amyloidosis, lightbefore she had a cadaver renal transplant in May chain nephropathy, or immune-complex deposits. 1986. The donor was not diabetic, and a biopsy of the Three months later the graft function deteriorated allograft performed during the transplant operation further and the patient required regular haemodialysis. showed a kidney of normal histology apart from mild non-specific mesangial proliferation (Figure 1 was hypertensive but not diabetic. His mother had no other complication on follow-up apart from hypertension, which was well controlled. non-insulin-dependent diabetes.
In September 1981 he had a live-related renal transIn March 1983 the patient was found to be diabetic, but with no proteinuria or retinopathy. He was started plant from his brother. Graft function was good with serum creatinine of 60-65 mmol/l. Immunosuppression on glibenclamide with good control of his blood sugar.
In November 1989 he was investigated for elevated consisted of azathioprine and prednisolone. There was A. K. Owda et al. 2006 liver enzymes, and his liver biopsy showed chronic in renal allografts [5] [6] [7] . The classic lesion of nodular diabetic glomerulosclerosis is rare after renal active hepatitis. Azathioprine was stopped and cyclosporin introduced instead. Consequently his blood transplantation. In recurrent diabetic nephropathy, Hariharan et al. [8] found it in two of 14 cases sugar went out of control, requiring insulin. Still there was no proteinuria and he continued to have a normal compared to diffuse glomerulosclerosis, which was observed in nine of 14 cases. graft function.
In April 1992 the patient was evaluated for chest A single case of de novo diabetic nodular sclerosis was reported by Schwarz et al. [7] , in a woman on pain, and coronary angiography showed extensive 3-vessels disease. Later he was discovered to be positive maintenance azathioprine and prednisolone. She developed diabetes 8 months after transplantation. for hepatitis C virus, and a repeat liver biopsy showed chronic active hepatitis. In December 1995 he Sixteen years after transplantation she was observed to have retinopathy, neuropathy, peripheral vascular developed proteinuria of 1.3 g/day which progressed slowly until May 1998 when he presented with massive disease, and nephropathy with non-nephrotic range proteinuria (<1 g/day). Within few months she proproteinuria of 15 g/day. He underwent a renal graft biopsy that showed changes of diabetic nephropathy gressed to maintenance dialysis.
Our case 1 also developed diabetes 8 months after with diffuse mesangial proliferation and expansion in addition to hyaline fibrin caps. Immunofluorescence transplantation. She developed severe nephrotic syndrome with rapid progression to end-stage renal failure was positive only for fibrinogen. Electron microscopy showed basement membrane thickening with no 9 years after transplantation. Nodular diabetic glomerulosclerosis ( Kimmelstiel-Wilson lesions) was docuimmune deposits. He had early background retinopathy on fundal examination and his renal function mented by histology. Remarkably, there was no retinopathy. showed some deterioration with doubling of the serum creatinine to 130-140 mmol/l.
There are some reports in the literature concerning diffuse diabetic glomerulosclerosis in graft recipients.
Case 3
Gimenez et al.
[5] reported a man who developed PTDM 9 months after transplantation and nephrotic A non-diabetic 56-year-old woman with hypertensive syndrome with progressive renal impairment 11 years nephrosclerosis had a second cadaver transplant in later. Sharma et al.
[6 ] reported a man on maintenance April 1988. She was maintained on azathioprine, azathioprine and prednisolone, and who developed prednisolone, and cyclosporin. She had a well-PTDM 2 years after the transplant, and developed functioning graft with a serum creatinine of proteinuria of 2 g/day in the absence of retinopathy; 90-100 mmol/l. Six months after transplantation she with progression to end-stage renal failure 10 years developed persistent hyperglycaemia and she was later. started on glibenclamide.
Our two patients with de novo diffuse diabetic glomIn October 1993, the patient became positive for erulosclerosis developed PTDM at 6 months and at 2 hepatitis C virus and accordingly azathioprine was years post-transplantation, both were maintained on stopped while the dose of cyclosporin was increased cyclosporin and prednisolone when they developed without any alteration of glycaemic control. There was their diabetes and they progressed to nephrotic synno proteinuria. In October 1996, she developed mild drome with functional impairment of renal function at ankle oedema and significant protein excretion of 9 and 16 years respectively. 2.1 g/day. She had no retinopathy or peripheral sensory Earlier reports commented that graft failure from neuropathy; graft function remained stable. diabetic lesions was rare. In the report of Mauer et al. In September 1997, the patient developed proteinuria [9] diabetic glomerular changes were demonstrated of 5.65 g/day. Her renal function showed some deteri-within 2 years of transplanting normal kidneys into oration as reflected by an increase in serum creatinine diabetics, but graft failure was thought to be rare at concentration from 100 to 150 mmol/l. She underwent least before the 10th year after transplant. On the a renal graft biopsy that showed features of diabetic other hand Hariharan et al.
[8] studied 14 patients nephropathy with mesangial proliferation, arteriolar with recurrent diabetic nephropathy, and found severe hyaline deposits, and moderate fibrosis with tubular advanced morphological changes after a mean of 8 atrophy on light microscopy, mesangial proliferation, years, in some cases even after no more than 41 months diffuse thickening of the glomerular basement mem-post-transplant. brane, and absence of dense deposits on electron Our patients developed PTDM at a mean time of microscopy and deposits of C 3 and IgG on immuno-13 months, all had nephrotic syndrome with functional fluorescence. The patient's creatinine remained stable impairment of graft function, and case 1 had a rapid at 150 mmol/l. and her diabetes is controlled with progression to end-stage renal failure after 9 years, glibenclamide.
indicative of the progressive nature of this disease. This finding is supported by a recent study by Miles 
